These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Sequence specificity, conformation, and recognition by HMG1 protein of major DNA interstrand cross-links of antitumor dinuclear platinum complexes. Kasparkova J; Farrell N; Brabec V J Biol Chem; 2000 May; 275(21):15789-98. PubMed ID: 10747955 [TBL] [Abstract][Full Text] [Related]
8. Site-specific d(GpG) intrastrand cross-links formed by dinuclear platinum complexes. Bending and NMR studies. Kaspárková J; Mellish KJ; Qu Y; Brabec V; Farrell N Biochemistry; 1996 Dec; 35(51):16705-13. PubMed ID: 8988007 [TBL] [Abstract][Full Text] [Related]
9. Effect of geometric isomerism in dinuclear platinum antitumor complexes on DNA interstrand cross-linking. Kaspárková J; Nováková O; Vrána O; Farrell N; Brabec V Biochemistry; 1999 Aug; 38(34):10997-1005. PubMed ID: 10460154 [TBL] [Abstract][Full Text] [Related]
10. Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins. Ohndorf UM; Rould MA; He Q; Pabo CO; Lippard SJ Nature; 1999 Jun; 399(6737):708-12. PubMed ID: 10385126 [TBL] [Abstract][Full Text] [Related]
11. HMG-domain protein recognition of cisplatin 1,2-intrastrand d(GpG) cross-links in purine-rich sequence contexts. Cohen SM; Mikata Y; He Q; Lippard SJ Biochemistry; 2000 Sep; 39(38):11771-6. PubMed ID: 10995245 [TBL] [Abstract][Full Text] [Related]
12. Recognition of DNA interstrand cross-links of cis-diamminedichloroplatinum(II) and its trans isomer by DNA-binding proteins. Kaspárková J; Brabec V Biochemistry; 1995 Sep; 34(38):12379-87. PubMed ID: 7547982 [TBL] [Abstract][Full Text] [Related]
13. Thermal and thermodynamic properties of duplex DNA containing site-specific interstrand cross-link of antitumor cisplatin or its clinically ineffective trans isomer. Hofr C; Brabec V J Biol Chem; 2001 Mar; 276(13):9655-61. PubMed ID: 11104778 [TBL] [Abstract][Full Text] [Related]
14. Long range 1,4 and 1,6-interstrand cross-links formed by a trinuclear platinum complex. Minor groove preassociation affects kinetics and mechanism of cross-link formation as well as adduct structure. Hegmans A; Berners-Price SJ; Davies MS; Thomas DS; Humphreys AS; Farrell N J Am Chem Soc; 2004 Feb; 126(7):2166-80. PubMed ID: 14971952 [TBL] [Abstract][Full Text] [Related]
15. Effects of a piperidine ligand on DNA modification by antitumor cisplatin analogues. Kasparkova J; Novakova O; Najajreh Y; Gibson D; Perez JM; Brabec V Chem Res Toxicol; 2003 Nov; 16(11):1424-32. PubMed ID: 14615968 [TBL] [Abstract][Full Text] [Related]
16. DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent. Brabec V; Kaspárková J; Vrána O; Nováková O; Cox JW; Qu Y; Farrell N Biochemistry; 1999 May; 38(21):6781-90. PubMed ID: 10346899 [TBL] [Abstract][Full Text] [Related]
17. NMR solution structure of a DNA dodecamer duplex containing a cis-diammineplatinum(II) d(GpG) intrastrand cross-link, the major adduct of the anticancer drug cisplatin. Gelasco A; Lippard SJ Biochemistry; 1998 Jun; 37(26):9230-9. PubMed ID: 9649303 [TBL] [Abstract][Full Text] [Related]
18. Solution structures of a DNA dodecamer duplex with and without a cisplatin 1,2-d(GG) intrastrand cross-link: comparison with the same DNA duplex containing an oxaliplatin 1,2-d(GG) intrastrand cross-link. Wu Y; Bhattacharyya D; King CL; Baskerville-Abraham I; Huh SH; Boysen G; Swenberg JA; Temple B; Campbell SL; Chaney SG Biochemistry; 2007 Jun; 46(22):6477-87. PubMed ID: 17497831 [TBL] [Abstract][Full Text] [Related]
19. DNA sequence context and protein composition modulate HMG-domain protein recognition of cisplatin-modified DNA. Dunham SU; Lippard SJ Biochemistry; 1997 Sep; 36(38):11428-36. PubMed ID: 9298962 [TBL] [Abstract][Full Text] [Related]